Not applicableStudy completedNCT00712556What this trial is testingPET Study in Patients With Non-Hodgkin LymphomaWho this might be right forLymphoma Vanderbilt-Ingram Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT01098656What this trial is testingLenalidomide Maintenance Post-debulking in Advanced CTCLWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 21
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Early research (Phase 1)Ended earlyNCT01738594What this trial is testingDose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell LymphomaWho this might be right forRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+11 more Northwestern University 7
Early research (Phase 1)Study completedNCT01254578What this trial is testingLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Ended earlyNCT00004239What this trial is testing506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00030849What this trial is testingBexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00293345What this trial is testing3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00963274What this trial is testingBortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 18
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Ended earlyNCT00005788What this trial is testingInterleukin-2 in Treating Patients With Mycosis Fungoides or Sezary SyndromeWho this might be right forLymphoma Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00611351What this trial is testingBusulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+4 more University of Nebraska 5
Early research (Phase 1)Ended earlyNCT00933985What this trial is testingObatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forAcute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT00004904What this trial is testingStem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Northwestern University
Early research (Phase 1)Study completedNCT00002687What this trial is testingInterleukin-2 in Treating Patients With Mycosis FungoidesWho this might be right forLymphoma University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03409432What this trial is testingBrentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more John Reneau 26
Early research (Phase 1)Study completedNCT00002759What this trial is testingIrinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaWho this might be right forDrug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more National Cancer Institute (NCI) 3